The exact pathway of bladder cancer carcinogenesis in correlation with FGFR3 is not established, yet some data showed that FGFR3 mutations suppressed the inflammatory response in early stages and that further inflammation was corelated rather with progression than with FGFR3 mutation [55]. Here, FGFR3 is linked to urinary bladder carcinoma.